Clinical Trial Update: Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating metformin hydrochloride with carboplatin and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal cancer has been wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Ovarian Epithelial Cancer
• Ovarian Germ Cell Tumor
• Ovarian Papillary Serous Carcinoma
• Ovarian Serous Cystadenocarcinoma
• Peritoneal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• METFORMIN HYDROCHLORIDE (Metformin hydrochloride)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Ovarian Papillary Serous Carcinoma, Ovarian Serous Cystadenocarcinoma | Phase 1 | Status: WITHDRAWN